Concepedia

Tania O. Stean

TO

36

Publications

3.3K

Citations

25

H-Index

1995

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Molecular Discovery (United Kingdom)

New Frontier

GlaxoSmithKline (Italy)

University College Dublin

Tania O. Stean is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, medicine, and neuropharmacology.

Top concepts

Publications per year

1995–2013

36

Publications

36

SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist

G.A. Kennett, Martyn Wood, Fiona Bright et al. · Neuropharmacology · 1997 · 523 citations · Full text

, , +9

GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models

Andrew D. Medhurst, A.R. Atkins, I.J.M. Beresford et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 300 citations

The Voltage-Gated Sodium Channel Na <sub>v</sub> 1.9 Is an Effector of Peripheral Inflammatory Pain Hypersensitivity

Fumimasa Amaya, Haibin Wang, Michael Costigan et al. · Journal of Neuroscience · 2006 · 292 citations · Full text

Characterization of SB‐269970‐A, a selective 5‐HT<sub>7</sub> receptor antagonist

Jim J. Hagan, Gary Price, Nigel Deeks et al. · British Journal of Pharmacology · 2000 · 281 citations · Full text

Epileptogenesis and Enhanced Prepulse Inhibition in GABAB1-Deficient Mice

Haydn M. Prosser, Catherine H. Gill, Warren D. Hirst et al. · Molecular and Cellular Neuroscience · 2001 · 279 citations

, , +3

Rows per page

1–5 of 36